MACROH2A1 and Alzheimer disease: Since our data are limited to mRNA levels coding for mH2A1, we cannot draw conclusions about potential differences in mH2A1 histone variant incorporation into the chromatin of 3xTg-AD brains or its reversal with an immunosuppressive drug.